Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03815942
What this trial is testing

VAccination in Early and ADvanced Prostate caNCEr

Who this might be right for
Intermediate Risk Prostate CancerCastration-resistant Prostate Cancer
University of Oxford 23
Not applicableUnknownNCT01478412
What this trial is testing

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
John Chang, MD 20
Not applicableLooking for participantsNCT06052683
What this trial is testing

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 208
Testing effectiveness (Phase 2)Looking for participantsNCT02391051
What this trial is testing

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial

Who this might be right for
Prostate Cancer
University of Erlangen-Nürnberg Medical School 50
Not applicableLooking for participantsNCT06866041
What this trial is testing

Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance

Who this might be right for
Low-Risk Prostate Cancer
Università Vita-Salute San Raffaele 74
Not applicableStudy completedNCT01578902
What this trial is testing

Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 84
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Not applicableActive Not RecruitingNCT02723734
What this trial is testing

Validation Study on the Impact of Decipher® Testing - VANDAAM Study

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 240
Post-approval studies (Phase 4)UnknownNCT05631080
What this trial is testing

Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage IBladder Outlet Obstruction
Mansoura University 50
Not applicableStudy completedNCT02079025
What this trial is testing

Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate CancerCancer of the Prostate
Exact Imaging 1,676
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Not applicableUnknownNCT01830166
What this trial is testing

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 10
Testing effectiveness (Phase 2)Study completedNCT00547339
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 94
Not applicableLooking for participantsNCT03830788
What this trial is testing

Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy

Who this might be right for
Prostate Cancer
Center Eugene Marquis 240
Not applicableLooking for participantsNCT03789253
What this trial is testing

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage I
National Taiwan University Hospital 300
Not applicableLooking for participantsNCT06661122
What this trial is testing

Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Low-volume Metastasis
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT04530552
What this trial is testing

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Who this might be right for
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
National Cancer Institute (NCI) 34
Not applicableUnknownNCT04228055
What this trial is testing

Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)

Who this might be right for
Prostate Cancer
University of Arizona 36
Next Page